Your browser doesn't support javascript.
loading
IL-10 producing regulatory B cells are decreased in blood from smokers and COPD patients.
Jacobs, Merel; Verschraegen, Sven; Salhi, Bihiyga; Anckaert, Jasper; Mestdagh, Pieter; Brusselle, Guy G; Bracke, Ken R.
Afiliação
  • Jacobs M; Laboratory for Translational Research in Obstructive Pulmonary Diseases, Department of Respiratory Medicine, Ghent University Hospital, C. Heymanslaan 10, 9000, Ghent, Belgium.
  • Verschraegen S; Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
  • Salhi B; Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
  • Anckaert J; Center for Medical Genetics, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Mestdagh P; OncoRNALab, Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
  • Brusselle GG; Center for Medical Genetics, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
  • Bracke KR; OncoRNALab, Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
Respir Res ; 23(1): 287, 2022 Oct 17.
Article em En | MEDLINE | ID: mdl-36253785
ABSTRACT

BACKGROUND:

Two opposing B cell subsets have been defined based on their cytokine profile IL-6 producing effector B cells (B-effs) versus IL-10 producing regulatory B cells (B-regs) that respectively positively or negatively regulate immune responses. B-regs are decreased and/or impaired in many autoimmune diseases and inflammatory conditions. Since there is increasing evidence that links B cells and B cell-rich lymphoid follicles to the pathogenesis of COPD, the aim of this study was to investigate the presence and function of B-regs in COPD.

METHODS:

First, presence of IL-10 producing regulatory B cells in human lung tissue was determined by immunohistochemistry. Secondly, quantification of IL-10 + B-regs and IL-6 + B-effs in peripheral blood mononuclear cells (PBMCs) from healthy controls, smokers without airflow limitation, and COPD patients (GOLD stage I-IV) was performed by flow cytometry. Thirdly, we exposed blood-derived B cells from COPD patients in vitro to cigarette smoke extract (CSE) and quantified IL-10 + B-regs and IL-6 + B-effs. Furthermore, we aimed at restoring the perturbed IL10 production by blocking BAFF. Fourthly, we determined mRNA expression of transcription factors involved in IL-10 production in FACS sorted memory- and naive B cells upon exposure to medium or CSE.

RESULTS:

The presence of IL-10 producing regulatory B cells in parenchyma and lymphoid follicles in lungs was confirmed by immunohistochemistry. The percentage of IL-10 + B-regs was significantly decreased in blood-derived memory B cell subsets from smokers without airflow limitation and patients with COPD, compared to never smokers. Furthermore, the capacity of B cells to produce IL-10 was reduced upon in vitro exposure to CSE and this could not be restored by BAFF-blockade. Finally, upon CSE exposure, mRNA levels of the transcription factors IRF4 and HIF-1α, were decreased in memory B cells.

CONCLUSION:

Decreased numbers and impaired function of B-regs in smokers and patients with COPD might contribute to the initiation and progression of the disease.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Linfócitos B Reguladores Limite: Humans Idioma: En Revista: Respir Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Linfócitos B Reguladores Limite: Humans Idioma: En Revista: Respir Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica
...